Viral Vector Development and Manufacturing

Viral Vector Development and Manufacturing

Products & Services

Information

There is no one-size-fits-all solution for viral vector manufacturing. Just like the therapy you are developing, you require a tailored approach. NecstGen offers a wide range of services and expert professionals to support you with that. Development: - Translational activities to create GMP compliant manufacturing - Process design and optimisation - Scale-up to clinically relevant volumes - Automation and closed processes Manufacturing: - Pre-clinical or toxicology study material - Phase I to Phase III clinical trial material Viral Vector: - Lentiviruses (LV) - Adeno-associated viruses (AAV) - Oncolytic viruses - Others We will be happy to discuss and help you bring your cell and gene therapies to patients.
NecstGen140NecstGen is a non-profit CDMO and centre of excellence for Cell and Gene Therapy, located in a purpose-built GMP facility on the largest bio-cluster in the Netherlands, Leiden Bio Science Park. Here, NecstGen provides critical contract development, manufacturing and rental services to academic and industrial therapy developers to deliver a new generation of therapies to patients. NecstGen offers: Full contract manufacturing services for Cell Therapy and Viral Vector; Process design, scale-up, optimization and automation for Cell Therapy and Viral Vector; Assay development for in-process, release, and potency; Cleanroom rental including services for QA, QC, and QP.

Log in

See all the content and easy-to-use features by logging in or registering!